Guidelines for conducting tuberculin skin test surveys in high-prevalence countries

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue SUPPL. 1, 2011, Pages

  Rieder, Hans L ^a,b   Chadha, Vineet K ^c   Nagelkerke, Nico J D ^d   Van Leth, Frank ^e,f   Van Der Werf, Marieke J ^e,f  

^a International Union Against Tuberculosis and Lung Disease ^*  (France)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c NATIONAL TUBERCULOSIS INSTITUTE   (India)

^d UNIVERSITY OF MANITOBA   (Canada)

^e KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; TUBERCULIN;

BCG VACCINATION; BUDGET; DATA ANALYSIS; HEALTH CARE PLANNING; HEALTH CARE SURVEY; HEALTH SERVICE; HOSPITAL PURCHASING; HUMAN; INFECTION RISK; INFORMATION PROCESSING; INJECTION SITE INDURATION; MEDICAL ETHICS; MYCOBACTERIUM TUBERCULOSIS; ORGANIZATION AND MANAGEMENT; PALPATION; PATIENT PARTICIPATION; PREVALENCE; PRIORITY JOURNAL; PROCESS DESIGN; PROFESSIONAL STANDARD; REVIEW; SAMPLE SIZE; SCAR FORMATION; SKIN IRRITATION; STRATIFIED SAMPLE; SYRINGE; TEAM BUILDING; TEAMWORK; TRAINING; TUBERCULIN TEST; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

ENDEMIC DISEASES; HEALTH SURVEYS; HUMANS; PREDICTIVE VALUE OF TESTS; PREVALENCE; REPRODUCIBILITY OF RESULTS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 78650802840     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Mack U, Migliori G B, Sester M, Rieder H L, Ehlers S, Goletti D, et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 2009; 33: 956-973.
2. Kim H K, Magnusson M, Weis Bentzon M. Tuberculin production. Acta Path Microbiol Scand 1964; 60: 557-570.
3. Palmer C E, Edwards L B, Hopwood L, Edwards P Q. Experimental and epidemiologic basis for the interpretation of tuberculin sensitivity. J Pediatr 1969; 55: 413-429.
4. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and nontuberculous mycobacteria? Int J Tuberc Lung Dis 2006; 10: 1192-1204.
5. Tuberculosis Prevention Trial Madras. Trial of BCG vaccines in South India for tuberculosis prevention. Indian J Med Res 1980; 72(Suppl): 1-74.
6. Arnadottir T, Rieder H L, Trébucq A, Waaler H T. Guidelines for conducting tuberculin skin test surveys in high prevalence countries. Tubercle Lung Dis 1996; 77(Suppl): S1-S20.
7. World Health Organization. The WHO standard tuberculin test. WHO/TB/Techn.Guide/3. Geneva, Switzerland: WHO, 1963.
8. ten Dam H G. Surveillance of tuberculosis by means of tuberculin surveys. WHO/TB/85.145. Geneva, Switzerland: WHO, 1985.
9. Bleiker M A, Sutherland I, Styblo K, ten Dam H G, Misljenovic O. Guidelines for estimating the risks of tuberculous infection from tuberculin test results in a representative sample of children. Bull Int Union Tuberc Lung Dis 1989; 64(2): 7-12.
10. Cauthen G M, Pio A, ten Dam H G. Annual risk of tuberculous infection. WHO/TB/88.154. Geneva, Switzerland: WHO, 1988.
11. Cauthen G M, Pio A, ten Dam H G. Annual risk of tuberculous infection. [Originally published as WHO document WHO/TB/88.154.] Bull World Health Organ 2002; 80: 503-511.
12. Cobelens F G, Egwaga S M, van Ginkel T, Muwinge H, Matee M I, Borgdorff M W. Tuberculin skin testing in patients with HIV infection: limited benefit of reduced cutoff values. Clin Infect Dis 2006; 43: 634-639. (Pubitemid 44267127)
13. Brouwer M. Skin test reactions in tuberculin surveys: preventive treatment with isoniazid or not? Thesis. Utrecht, The Netherlands: University of Utrecht, 2001.
14. Bachtiar A, Miko T Y, Machmud R, Besral B, Yudarini P, Mehta F, et al. Annual risks of tuberculous infection in East Nusa Tenggara and Central Java Provinces, Indonesia. Int J Tuberc Lung Dis 2009; 13: 32-38.
15. Comstock G W, Livesay V T, Woolpert S F. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974; 99: 131-138.
16. Vynnycky E, Fine P E M. Life time risks, incubation period, and serial interval of tuberculosis. Am J Epidemiol 2000; 152: 247-263. (Pubitemid 30640248)
17. Lobato M N, Jereb J A, Starke J R. Unintended consequences: mandatory tuberculin skin testing and severe isoniazid hepatotoxicity. Pediatrics 2008; 121: e1732-e1733.
18. Kuemmerer J M, Comstock G W. Sociologic concomitants of tuberculin sensitivity. Am Rev Respir Dis 1967; 96: 885-892.
19. Leung C C, Yew W W, Tam C M, et al. Tuberculin response in BCG vaccinated schoolchildren and the estimation of annual risk of infection in Hong Kong. Thorax 2005; 60: 124-129.
20. Sutherland I, Fayers P M. The association of the risk of tuberculous infection with age. Bull Int Union Tuberc 1975; 50: 70-81.
21. Nagelkerke N, Borgdorff M, Broekmans J. The estimation of trend in risk and age specific risk of tuberculous infection from repeated tuberculin surveys: a new semi-parametric method. Tuberculosis Surveillance Research Unit Progress Report 1997; 1: 3-16.
22. Nagelkerke N J D, Borgdorff M W, Kalisvaart N A, Broekmans J F. The design of multi-stage tuberculin surveys: some suggestions for sampling. Int J Tuberc Lung Dis 2000; 4: 314-320.
23. Snider D E Jr, Cauthen G M. Tuberculin skin testing of hospital employees: infection, 'boosting', and two-step testing. Am J Infect Control 1984; 12: 305-311. (Pubitemid 15148893)
24. Neuenschwander B E, Zwahlen M, Kim S J, Lee E G, Rieder H L. Determination of the prevalence of infection with Mycobacterium tuberculosis among persons vaccinated with bacillus Calmette-Guérin in South Korea. Am J Epidemiol 2002; 155: 654-663.
25. World Health Organization. WHO Expert Committee on Tu berculosis. Eighth report. Technical Report Series 1964; 290: 1-24.
26. World Health Organization. WHO Expert Committee on Tuberculosis. Ninth report. Technical Report Series 1974; 552: 1-40.
27. World Health Organization. Global Tuberculosis Programme and Global Programme on Vaccines. Statement on BCG revaccination for the prevention of tuberculosis. WHO Wkly Epidem Rec 1995; 70: 229-231.
28. Rodrigues L C, Pereira S M, Cunha S S, et al. Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVA cluster-randomised trial. Lancet 2005; 366: 1290-1295.
29. Neuenschwander B E, Zwahlen M, Kim S J, Engel R R, Rieder H L. Trends in the prevalence of infection with Mycobacterium tuberculosis in Korea from 1965 to 1995: an analysis of seven surveys by mixture models. Int J Tuberc Lung Dis 2000; 4: 719-729.
30. Guld J, Bentzon M W, Bleiker M A, Griep W A, Magnusson M, Waaler H. Standardization of a new batch of purified tuberculin (PPD) intended for international use. Bull World Health Organ 1958; 19: 845-951.
31. Comstock G W, Edwards L B, Philip R N, Winn W A. A comparison in the United States of America of two tuberculins, PPD-S and RT 23. Bull World Health Organ 1964; 31: 161-170.
32. Deck F, Guld J. Committee on Epidemiology and Statistics. The WHO tuberculin test. Bull Int Union Tuberc 1964; 34: 53-70.
33. Chadha V K, Jagannatha P S, Vaidyanathan P S, Jagota P. PPD RT23 for tuberculin surveys in India. Int J Tuberc Lung Dis 2003; 7: 172-179. (Pubitemid 36172679)
34. Mendel F. Die von Pirquetsche hautreaktion und die intravenöse tuberkulinbehandlung. Med Klin 1908; (No. 12): 402-404.
35. Mantoux C. L'intradermo-réaction à la tuberculine et son interprétation clinique. Presse Méd 1910; (no 2): 10-13.
36. Comstock G W. False tuberculin test results. Chest 1975; 68 (Suppl): 465-469.
37. Geldenhuys H, Verver S, Surtie S. The tuberculin skin test: a comparison of ruler and calliper readings. Int J Tuberc Lung Dis 2010; 14: 1266-1271.
38. Trébucq A, Guérin N, Ali Ismael H, Bernatas J J, Sèvre J P, Rieder H L. Prevalence and trends of infection with Mycobacterium tuberculosis in Djibouti, testing an alternative method. Int J Tuberc Lung Dis 2005; 9: 1097-1104.
39. Eilers P H C, Borgdorff M W. Modeling and correction of digit preference in tuberculin surveys. Int J Tuberc Lung Dis 2004; 8: 232-239.
40. Pai M, Dendukuri N, Wang L, Joshi R, Kalantri S, Rieder H L. Improving the estimation of tuberculosis infection prevalence using T-cell based assay and mixture models. Int J Tuberc Lung Dis 2008; 12: 895-902.
41. Neuenschwander B E. Bayesian mixture analysis for tuberculin induration data. Paris, France: International Union Against Tuberculosis and Lung Disease. http://www.tbrieder.org Accessed January 2010.
42. Tanzania Tuberculin Survey Collaboration. Tuberculosis control in the era of the HIV epidemic: risk of tuberculosis infection in Tanzania, 1983-1998. Int J Tuberc Lung Dis 2001; 5: 103-112.
43. Styblo K, Meijer J, Sutherland I. The transmission of tubercle bacilli - its trend in a human population. Tuberculosis surveillance research unit report no. 1. Bull Int Union Tuberc 1969; 42: 1-104.
44. Sutherland I. Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli. Adv Tuberc Res 1976; 19: 1-63.
45. Rieder H L. Methodological issues in the estimation of the tuberculosis problem from tuberculin surveys. Tubercle Lung Dis 1995; 76: 114-121.
46. van Leth F, van der Werf M J, Borgdorff M W. Prevalence of tuberculous infection and incidence of tuberculosis; a reassessment of the Styblo rule. Bull World Health Organ 2008; 86: 20-26.